Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content

Jessica A. Miller, Iman A Hakim, Wade Chew, Patricia Thompson, Cynthia Thomson, Hsiao-Hui Chow

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

d-Limonene is a bioactive food component found in high concentration in citrus peel oil with anticancer effects in preclinical studies of mammary carcinogenesis. Extrapolation of preclinical data to human cancer is limited, in part, by inadequate information on the oral bioavailability and tissue disposition of d-limonene in humans. As a fat-soluble compound, d-limonene is more likely to deposit in fatty tissues such as the breast. To assess disposition of d-limonene in humans, we conducted a pilot study of oral d-limonene-rich lemonade. Following a 1-wk washout period devoid of citrus, healthy adults consumed 40 oz. of freshly prepared lemonade containing 500 to 600 mg d-limonene daily for 4 wk. On the first and last consumption days, blood and buttock fat biopsy were collected. Matched preintervention and postintervention fat biopsies (n = 7), and matched preintervention and postintervention plasma samples (n = 6), were analyzed for d-limonene levels using gas chromatography and mass spectrometry. There was a significant increase in d-limonene levels in the fat biopsies after 4 wk (P = 0.009); initial levels ranged from nondetectable to 7.79 μmol/kg tissue, and postintervention levels ranged from 53.6 to 294 μmol/kg tissue. Plasma d-limonene levels increased from 0.35 to 0.72 μmol/l initially to postintervention levels of 0.54 to 1.65 μmol/l (P = 0.016). Postintervention adipose d-limonene levels were 51.0 to 195 times higher than plasma levels (P = 0.009). Our results demonstrate accumulation of d-limonene in adipose tissue after oral dosing and support additional studies of d-limonene for chemoprevention in tissues such as the breast that are comprised of a significant fat fraction.

Original languageEnglish (US)
Pages (from-to)783-788
Number of pages6
JournalNutrition and Cancer
Volume62
Issue number6
DOIs
StatePublished - Aug 2010

Fingerprint

Adipose Tissue
Fats
Breast
Citrus
Biopsy
limonene
Buttocks
Chemoprevention
Gas Chromatography-Mass Spectrometry
Biological Availability
Oils
Carcinogenesis
Food

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Oncology
  • Cancer Research

Cite this

Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content. / Miller, Jessica A.; Hakim, Iman A; Chew, Wade; Thompson, Patricia; Thomson, Cynthia; Chow, Hsiao-Hui.

In: Nutrition and Cancer, Vol. 62, No. 6, 08.2010, p. 783-788.

Research output: Contribution to journalArticle

@article{2e6c438a949044fab44c6a7dde2eb6f1,
title = "Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content",
abstract = "d-Limonene is a bioactive food component found in high concentration in citrus peel oil with anticancer effects in preclinical studies of mammary carcinogenesis. Extrapolation of preclinical data to human cancer is limited, in part, by inadequate information on the oral bioavailability and tissue disposition of d-limonene in humans. As a fat-soluble compound, d-limonene is more likely to deposit in fatty tissues such as the breast. To assess disposition of d-limonene in humans, we conducted a pilot study of oral d-limonene-rich lemonade. Following a 1-wk washout period devoid of citrus, healthy adults consumed 40 oz. of freshly prepared lemonade containing 500 to 600 mg d-limonene daily for 4 wk. On the first and last consumption days, blood and buttock fat biopsy were collected. Matched preintervention and postintervention fat biopsies (n = 7), and matched preintervention and postintervention plasma samples (n = 6), were analyzed for d-limonene levels using gas chromatography and mass spectrometry. There was a significant increase in d-limonene levels in the fat biopsies after 4 wk (P = 0.009); initial levels ranged from nondetectable to 7.79 μmol/kg tissue, and postintervention levels ranged from 53.6 to 294 μmol/kg tissue. Plasma d-limonene levels increased from 0.35 to 0.72 μmol/l initially to postintervention levels of 0.54 to 1.65 μmol/l (P = 0.016). Postintervention adipose d-limonene levels were 51.0 to 195 times higher than plasma levels (P = 0.009). Our results demonstrate accumulation of d-limonene in adipose tissue after oral dosing and support additional studies of d-limonene for chemoprevention in tissues such as the breast that are comprised of a significant fat fraction.",
author = "Miller, {Jessica A.} and Hakim, {Iman A} and Wade Chew and Patricia Thompson and Cynthia Thomson and Hsiao-Hui Chow",
year = "2010",
month = "8",
doi = "10.1080/01635581003693066",
language = "English (US)",
volume = "62",
pages = "783--788",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "6",

}

TY - JOUR

T1 - Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content

AU - Miller, Jessica A.

AU - Hakim, Iman A

AU - Chew, Wade

AU - Thompson, Patricia

AU - Thomson, Cynthia

AU - Chow, Hsiao-Hui

PY - 2010/8

Y1 - 2010/8

N2 - d-Limonene is a bioactive food component found in high concentration in citrus peel oil with anticancer effects in preclinical studies of mammary carcinogenesis. Extrapolation of preclinical data to human cancer is limited, in part, by inadequate information on the oral bioavailability and tissue disposition of d-limonene in humans. As a fat-soluble compound, d-limonene is more likely to deposit in fatty tissues such as the breast. To assess disposition of d-limonene in humans, we conducted a pilot study of oral d-limonene-rich lemonade. Following a 1-wk washout period devoid of citrus, healthy adults consumed 40 oz. of freshly prepared lemonade containing 500 to 600 mg d-limonene daily for 4 wk. On the first and last consumption days, blood and buttock fat biopsy were collected. Matched preintervention and postintervention fat biopsies (n = 7), and matched preintervention and postintervention plasma samples (n = 6), were analyzed for d-limonene levels using gas chromatography and mass spectrometry. There was a significant increase in d-limonene levels in the fat biopsies after 4 wk (P = 0.009); initial levels ranged from nondetectable to 7.79 μmol/kg tissue, and postintervention levels ranged from 53.6 to 294 μmol/kg tissue. Plasma d-limonene levels increased from 0.35 to 0.72 μmol/l initially to postintervention levels of 0.54 to 1.65 μmol/l (P = 0.016). Postintervention adipose d-limonene levels were 51.0 to 195 times higher than plasma levels (P = 0.009). Our results demonstrate accumulation of d-limonene in adipose tissue after oral dosing and support additional studies of d-limonene for chemoprevention in tissues such as the breast that are comprised of a significant fat fraction.

AB - d-Limonene is a bioactive food component found in high concentration in citrus peel oil with anticancer effects in preclinical studies of mammary carcinogenesis. Extrapolation of preclinical data to human cancer is limited, in part, by inadequate information on the oral bioavailability and tissue disposition of d-limonene in humans. As a fat-soluble compound, d-limonene is more likely to deposit in fatty tissues such as the breast. To assess disposition of d-limonene in humans, we conducted a pilot study of oral d-limonene-rich lemonade. Following a 1-wk washout period devoid of citrus, healthy adults consumed 40 oz. of freshly prepared lemonade containing 500 to 600 mg d-limonene daily for 4 wk. On the first and last consumption days, blood and buttock fat biopsy were collected. Matched preintervention and postintervention fat biopsies (n = 7), and matched preintervention and postintervention plasma samples (n = 6), were analyzed for d-limonene levels using gas chromatography and mass spectrometry. There was a significant increase in d-limonene levels in the fat biopsies after 4 wk (P = 0.009); initial levels ranged from nondetectable to 7.79 μmol/kg tissue, and postintervention levels ranged from 53.6 to 294 μmol/kg tissue. Plasma d-limonene levels increased from 0.35 to 0.72 μmol/l initially to postintervention levels of 0.54 to 1.65 μmol/l (P = 0.016). Postintervention adipose d-limonene levels were 51.0 to 195 times higher than plasma levels (P = 0.009). Our results demonstrate accumulation of d-limonene in adipose tissue after oral dosing and support additional studies of d-limonene for chemoprevention in tissues such as the breast that are comprised of a significant fat fraction.

UR - http://www.scopus.com/inward/record.url?scp=77955009350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955009350&partnerID=8YFLogxK

U2 - 10.1080/01635581003693066

DO - 10.1080/01635581003693066

M3 - Article

C2 - 20661827

AN - SCOPUS:77955009350

VL - 62

SP - 783

EP - 788

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 6

ER -